TearLab Corp. Company Profile (NASDAQ:TEAR)

About TearLab Corp.

TearLab Corp. logoTearLab Corporation is an in-vitro diagnostic company. The Company has commercialized a tear testing platform, the TearLab Osmolarity System, which enables eye care practitioners to test for sensitive and specific biomarkers using nanoliters of tear film at the point-of-care. The Company, through its subsidiary TearLab Research, Inc., develops technologies to enable eye care practitioners to test a range of biomarkers (chemistries, metabolites, genes and proteins) at the point-of-care. Its product, the TearLab Osmolarity System, enables the measurement of tear osmolarity in the doctor's office. The TearLab Osmolarity System consists of approximately three components: the TearLab disposable, the TearLab Pen, and the TearLab Reader. The TearLab disposable is a single-use microfluidic microchip. The TearLab Pen is a hand-held device that interfaces with the TearLab disposable. The TearLab Reader is a small desktop unit that allows for the docking of the TearLab Pen.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Laboratories & Research
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: TEAR
  • CUSIP:
Key Metrics:
  • Previous Close: $0.77
  • 50 Day Moving Average: $0.7747
  • 200 Day Moving Average: $0.7534
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -3.43
  • P/E Growth: -0.0700
  • Market Cap: $40.18M
  • Outstanding Shares: 52,898,000
  • Beta: 3.21
Additional Links:
Companies Related to TearLab Corp.:

Analyst Ratings

Consensus Ratings for TearLab Corp. (NASDAQ:TEAR) (?)
Ratings Breakdown: 1 Hold Rating, 3 Buy Ratings, 1 Strong Buy Rating
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $3.06 (287.66% upside)

Analysts' Ratings History for TearLab Corp. (NASDAQ:TEAR)
Show:
DateFirmActionRatingPrice TargetDetails
8/5/2016Rodman & RenshawReiterated RatingBuy$2.00View Rating Details
8/4/2016Roth CapitalDowngradeBuy -> NeutralView Rating Details
5/5/2016Feltl & Co.UpgradeBuy -> Strong-BuyView Rating Details
3/9/2016Canaccord GenuityReiterated RatingBuyView Rating Details
11/6/2015Craig HallumLower Price TargetBuy$5.00 -> $4.00View Rating Details
(Data available from 8/29/2014 forward)

Earnings

Earnings History for TearLab Corp. (NASDAQ:TEAR)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/3/2016        
8/3/2016Q2($0.08)($0.08)$6.95 million$6.90 millionViewN/AView Earnings Details
5/4/2016Q1($0.23)($0.21)$6.53 million$6.80 millionViewN/AView Earnings Details
3/8/2016Q4($0.25)($0.26)$6.83 million$6.80 millionViewN/AView Earnings Details
11/5/2015Q315($0.24)($0.24)$6.40 million$6.60 millionViewN/AView Earnings Details
8/6/2015Q215($0.25)($0.24)$5.72 million$6.30 millionViewN/AView Earnings Details
5/7/2015Q115($0.21)($0.25)$5.40 million$5.40 millionViewN/AView Earnings Details
3/12/2015Q414($0.17)($0.21)$5.50 million$5.30 millionViewN/AView Earnings Details
11/5/2014Q214($0.17)($0.17)$5.50 million$5.20 millionViewN/AView Earnings Details
8/7/2014Q114($0.16)($0.17)$5.12 million$9.20 millionViewN/AView Earnings Details
5/8/2014Q1($0.14)($0.17)$4.76 million$4.21 millionViewN/AView Earnings Details
3/13/2014Q413($0.13)($0.13)$4.49 million$4.40 millionViewN/AView Earnings Details
11/12/2013Q3($0.14)($0.13)$3.80 million$4.20 millionViewListenView Earnings Details
5/13/2013Q1 2013($0.12)($0.30)$2.18 million$2.47 millionViewN/AView Earnings Details
11/13/2012Q312($0.11)($0.10)$1.20 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for TearLab Corp. (NASDAQ:TEAR)
Current Year EPS Consensus Estimate: $-0.44 EPS
Next Year EPS Consensus Estimate: $-0.23 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20164($0.24)($0.22)($0.23)
Q2 20163($0.11)($0.06)($0.09)
Q3 20163($0.10)($0.08)($0.09)
Q4 20163($0.10)($0.08)($0.09)
Q1 20171($0.06)($0.06)($0.06)
Q2 20171($0.06)($0.06)($0.06)
Q3 20171($0.05)($0.05)($0.05)
Q4 20171($0.04)($0.04)($0.04)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for TearLab Corp. (NASDAQ:TEAR)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for TearLab Corp. (NASDAQ:TEAR)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/31/2016Brock WrightDirectorBuy59,686$0.78$46,555.08View SEC Filing  
5/26/2016Brock WrightDirectorBuy130,314$0.76$99,038.64View SEC Filing  
12/4/2014Elias VamvakasCEOBuy50,000$2.24$112,000.00View SEC Filing  
11/18/2014Elias VamvakasCEOBuy31,187$2.55$79,526.85View SEC Filing  
11/17/2014Elias VamvakasCEOBuy18,813$2.55$47,973.15View SEC Filing  
11/11/2014Elias VamvakasCEOBuy150,000$2.49$373,500.00View SEC Filing  
11/10/2014Elias VamvakasCEOBuy16,276$2.50$40,690.00View SEC Filing  
11/10/2014Joseph JensenCOOBuy43,375$2.31$100,196.25View SEC Filing  
8/20/2014Brock WrightDirectorBuy23,000$3.82$87,860.00View SEC Filing  
8/19/2014Brock WrightDirectorBuy11,354$3.83$43,485.82View SEC Filing  
8/12/2014Elias VamvakasCEOBuy70,000$3.43$240,100.00View SEC Filing  
6/30/2014Richard LindstromDirectorSell5,000$4.61$23,050.00View SEC Filing  
5/13/2014Elias VamvakasCEOBuy30,000$3.99$119,700.00View SEC Filing  
5/13/2014Joseph JensenCOOBuy48,693$4.11$200,128.23View SEC Filing  
4/1/2014Paul KarpeckiDirectorSell5,000$6.83$34,150.00View SEC Filing  
1/2/2014Paul KarpeckiDirectorSell5,000$9.47$47,350.00View SEC Filing  
12/31/2013Richard LindstromDirectorSell5,000$9.26$46,300.00View SEC Filing  
11/15/2013Richard LindstromDirectorSell5,000$8.95$44,750.00View SEC Filing  
10/11/2013Paul KarpeckiDirectorSell5,000$10.96$54,800.00View SEC Filing  
9/3/2013William DumencuCFOSell7,000$13.22$92,540.00View SEC Filing  
8/1/2013William DumencuCFOSell7,000$14.39$100,730.00View SEC Filing  
7/1/2013Paul KarpeckiDirectorSell5,000$10.62$53,100.00View SEC Filing  
7/1/2013William DumencuCFOSell7,000$10.61$74,270.00View SEC Filing  
6/3/2013William DumencuCFOSell7,000$11.35$79,450.00View SEC Filing  
4/2/2013Tom Jr. DavidsonDirectorBuy1,500$6.63$9,945.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for TearLab Corp. (NASDAQ:TEAR)
DateHeadline
News IconFan Favorite Spicy Korean Q Returns to Wingstop (NASDAQ:TEAR)
www.econotimes.com - August 29 at 10:40 AM
finance.yahoo.com logoTearLab Corporation to Present at the 5th Annual Liolios Gateway Conference on September 7, 2016 (NASDAQ:TEAR)
finance.yahoo.com - August 29 at 10:39 AM
News IconTearLab Corp (NASDAQ: TEAR) Has Strong Goals For 2016 - Scibility Media (NASDAQ:TEAR)
scibilitymedia.com - August 23 at 12:15 PM
finance.yahoo.com logoTEARLAB CORP Financials (NASDAQ:TEAR)
finance.yahoo.com - August 13 at 7:16 PM
capitalcube.com logoETF’s with exposure to TearLab Corp. : August 11, 2016 (NASDAQ:TEAR)
www.capitalcube.com - August 11 at 8:19 PM
News IconMedicare spending climbs as physicians provide more tests in their offices (NASDAQ:TEAR)
www.beckershospitalreview.com - August 10 at 8:18 PM
capitalcube.com logoTearLab Corp. :TEAR-US: Earnings Analysis: Q2, 2016 By the Numbers : August 9, 2016 (NASDAQ:TEAR)
www.capitalcube.com - August 9 at 8:03 PM
reuters.com logoBRIEF-AWM Investment Company, Inc reports 12.8 pct passive stake in Tearlab (NASDAQ:TEAR)
www.reuters.com - August 5 at 7:57 PM
finance.yahoo.com logoTearLab downgraded by ROTH Capital (NASDAQ:TEAR)
finance.yahoo.com - August 4 at 8:13 PM
globenewswire.com logoTearLab Corporation Reports Second Quarter and June Year-To-Date 2016 Financial Results (NASDAQ:TEAR)
globenewswire.com - August 4 at 10:56 AM
reuters.com logoBRIEF-Tearlab Corp reports Q2 and June YTD 2016 financial results (NASDAQ:TEAR)
www.reuters.com - August 4 at 10:56 AM
biz.yahoo.com logoTEARLAB CORP Files SEC form 10-Q, Quarterly Report (NASDAQ:TEAR)
biz.yahoo.com - August 4 at 10:56 AM
nasdaq.com logoTearLab Corporation Reports Second Quarter and June Year-To-Date 2016 Financial Results - Nasdaq (NASDAQ:TEAR)
www.nasdaq.com - August 3 at 8:05 PM
reuters.com logoBRIEF-Tearlab Corp reports Q2 and June YTD 2016 financial results - Reuters (NASDAQ:TEAR)
in.reuters.com - August 3 at 8:05 PM
sg.finance.yahoo.com logoTearLab reports 2Q loss (NASDAQ:TEAR)
sg.finance.yahoo.com - August 3 at 8:05 PM
biz.yahoo.com logoQ2 2016 TearLab Corp Earnings Release - After Market Close (NASDAQ:TEAR)
biz.yahoo.com - August 3 at 11:02 AM
News IconA Game Changer in the Treatment of Dry Eye (NASDAQ:TEAR)
www.medscape.com - July 26 at 11:12 AM
investornewswire.com logoCan TearLab Corporation (NASDAQ:TEAR) Surprise Analysts this Quarter? - Investor Newswire (NASDAQ:TEAR)
www.investornewswire.com - July 25 at 7:57 PM
News IconTearLab Corporation (NASDAQ:TEAR): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily (NASDAQ:TEAR)
www.engelwooddaily.com - July 22 at 7:33 PM
News IconWhat's Ahead for TearLab Corp After Forming Bearish Multiple Bottom Chart Pattern? - Consumer Eagle (NASDAQ:TEAR)
www.consumereagle.com - July 22 at 10:41 AM
finance.yahoo.com logo4 Medical Instrument Stocks to Bet on This Earnings Season (NASDAQ:TEAR)
finance.yahoo.com - July 22 at 9:51 AM
4-traders.com logoSHIRE PLC : Financial Statements and Exhibits (form 8-K) (NASDAQ:TEAR)
www.4-traders.com - July 21 at 8:06 PM
News IconInsiders Increasing Positions in: TearLab Corporation (NASDAQ:TEAR) - Press Telegraph (NASDAQ:TEAR)
presstelegraph.com - July 21 at 10:33 AM
News IconEquity Roundup: Stock Performance Focus on TearLab Corporation (NASDAQ:TEAR) - Press Telegraph (NASDAQ:TEAR)
presstelegraph.com - July 21 at 10:33 AM
News IconHow Analysts Feel About TearLab Corp (NASDAQ:TEAR)? - Press Telegraph (NASDAQ:TEAR)
presstelegraph.com - July 21 at 10:33 AM
News IconStock Focus: Following Analyst Expectations on Shares of TearLab Corporation (NASDAQ:TEAR) - TGP (NASDAQ:TEAR)
telanaganapress.com - July 20 at 8:46 PM
globenewswire.com logoTearLab Corporation to Release Second Quarter 2016 Financial Results - GlobeNewswire (press release) (NASDAQ:TEAR)
globenewswire.com - July 20 at 8:46 PM
finance.yahoo.com logoTearLab Corporation to Release Second Quarter 2016 Financial Results (NASDAQ:TEAR)
finance.yahoo.com - July 20 at 8:30 AM
News IconRodman & Renshaw Initiates Coverage on TearLab Corp to Buy - TheFounders Daily (NASDAQ:TEAR)
www.thefoundersdaily.com - July 19 at 8:44 AM
capitalcube.com logoETF’s with exposure to TearLab Corp. : July 18, 2016 (NASDAQ:TEAR)
www.capitalcube.com - July 18 at 2:24 PM
fiscalstandard.com logoNext Weeks Broker Price Targets For TearLab Corporation (TEAR) - Fiscal Standard (NASDAQ:TEAR)
www.fiscalstandard.com - July 17 at 10:31 AM
News IconAnalyst Target and Average Rating Watch: TearLab Corporation (NASDAQ:TEAR) - Press Telegraph (NASDAQ:TEAR)
presstelegraph.com - July 16 at 10:53 AM
News IconTearLab Corporation (NASDAQ:TEAR) Earnings Concentration and Analyst Target Watch - Engelwood Daily (NASDAQ:TEAR)
www.engelwooddaily.com - July 15 at 6:42 PM
stocksdaily.net logoWhat Is Mean Rating On TearLab Corporation (NASDAQ:TEAR)? - Stocks Daily (NASDAQ:TEAR)
www.stocksdaily.net - July 15 at 6:42 PM
News IconThe FDA Confirms The Approval of Xiidra From TearLab Corp (NASDAQ:TEAR) - Journal Transcript (NASDAQ:TEAR)
www.journaltranscript.com - July 15 at 6:42 PM
News IconStock Watch: Unusual Volume Seen on Shares of TearLab Corporation (NASDAQ:TEAR) - Engelwood Daily (NASDAQ:TEAR)
www.engelwooddaily.com - July 14 at 8:00 PM
News IconTrading Performance and Target Watch for TearLab Corporation (NASDAQ:TEAR) - Press Telegraph (NASDAQ:TEAR)
presstelegraph.com - July 14 at 8:00 PM
News IconTearLab Corporation (NASDAQ:TEAR) Wall Street Analyst Recommendation Outlook - Telanagana Press (NASDAQ:TEAR)
telanaganapress.com - July 13 at 8:07 PM
News IconEye Catching Stocks - TearLab, (NASDAQ:TEAR), Devon Energy, (NYSE:DVN) - Hot Stocks Point (NASDAQ:TEAR)
www.hotstockspoint.com - July 13 at 8:07 PM
globenewswire.com logoTearLab Corporation Comments on Shire plc FDA Approval of Xiidra™ (lifitegrast ophthalmic solution) 5% - GlobeNewswire (press release) (NASDAQ:TEAR)
globenewswire.com - July 13 at 8:07 PM
News IconSolarCity Corp (NASDAQ:SCTY) & TearLab Corp (NASDAQ:TEAR) Traders Recap - Money News (press release) (NASDAQ:TEAR)
www.newsismoney.com - July 13 at 8:06 PM
streetinsider.com logoTearLab (TEAR) Calls Shire's FDA Approval of Xiidra an Important Milestone for DED (NASDAQ:TEAR)
www.streetinsider.com - July 13 at 10:39 AM
benzinga.com logoWhy This Analyst Sees TearLab Shares Tripling (NASDAQ:TEAR)
www.benzinga.com - July 12 at 8:00 PM
publicnow.com logoTearLab Corporation Comments on Shire plc FDA Approval of Xiidra™ (lifitegrast ophthalmic solution) 5% (NASDAQ:TEAR)
www.publicnow.com - July 12 at 4:23 PM
News IconStock Rating Watch and Earnings Insight for TearLab Corporation (NASDAQ:TEAR) - Press Telegraph (NASDAQ:TEAR)
presstelegraph.com - July 11 at 10:30 AM
news.cmlviz.com logoTearLab Corporation (NasdaqCM:TEAR) Fundamental Star Rating Report - CML News (NASDAQ:TEAR)
news.cmlviz.com - July 11 at 10:30 AM
News IconCompany Stock Focus for TearLab Corporation (NASDAQ:TEAR): Which Way Will Shares Head? - Press Telegraph (NASDAQ:TEAR)
presstelegraph.com - July 9 at 10:44 AM
News IconTearlab Corporation (NASDAQ:TEAR) Short Interest Decreased By 2.94% - Press Telegraph (NASDAQ:TEAR)
presstelegraph.com - July 9 at 10:44 AM
News IconCan TearLab Corporation (NASDAQ:TEAR) Improve on the Earnings Front? - Engelwood Daily (NASDAQ:TEAR)
www.engelwooddaily.com - July 7 at 7:51 PM
capitalcube.com logoETF’s with exposure to TearLab Corp. : July 6, 2016 (NASDAQ:TEAR)
www.capitalcube.com - July 6 at 2:43 PM

Social

TearLab Corp. (NASDAQ:TEAR) Chart for Monday, August, 29, 2016


Last Updated on 8/29/2016 by MarketBeat.com Staff